nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Eczema—Sorafenib—liver cancer	0.0158	0.0322	CcSEcCtD
Scopolamine—Dry skin—Sorafenib—liver cancer	0.013	0.0265	CcSEcCtD
Scopolamine—Dysphagia—Sorafenib—liver cancer	0.0123	0.025	CcSEcCtD
Scopolamine—Redness—Epirubicin—liver cancer	0.0107	0.0218	CcSEcCtD
Scopolamine—Redness—Doxorubicin—liver cancer	0.00993	0.0202	CcSEcCtD
Scopolamine—Urinary tract disorder—Sorafenib—liver cancer	0.00972	0.0197	CcSEcCtD
Scopolamine—Urethral disorder—Sorafenib—liver cancer	0.00965	0.0196	CcSEcCtD
Scopolamine—Amblyopia—Epirubicin—liver cancer	0.00938	0.0191	CcSEcCtD
Scopolamine—Flushing—Sorafenib—liver cancer	0.00914	0.0186	CcSEcCtD
Scopolamine—Arrhythmia—Sorafenib—liver cancer	0.0088	0.0179	CcSEcCtD
Scopolamine—Amblyopia—Doxorubicin—liver cancer	0.00868	0.0176	CcSEcCtD
Scopolamine—Mental disorder—Sorafenib—liver cancer	0.00863	0.0175	CcSEcCtD
Scopolamine—Erythema—Sorafenib—liver cancer	0.00857	0.0174	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00725	0.0147	CcSEcCtD
Scopolamine—Dry mouth—Sorafenib—liver cancer	0.00714	0.0145	CcSEcCtD
Scopolamine—Nervous system disorder—Sorafenib—liver cancer	0.00686	0.0139	CcSEcCtD
Scopolamine—Skin disorder—Sorafenib—liver cancer	0.0068	0.0138	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—liver cancer	0.00669	0.0136	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—liver cancer	0.00619	0.0126	CcSEcCtD
Scopolamine—Fatigue—Sorafenib—liver cancer	0.00603	0.0122	CcSEcCtD
Scopolamine—Pain—Sorafenib—liver cancer	0.00598	0.0121	CcSEcCtD
Scopolamine—Constipation—Sorafenib—liver cancer	0.00598	0.0121	CcSEcCtD
Scopolamine—Eczema—Epirubicin—liver cancer	0.00585	0.0119	CcSEcCtD
Scopolamine—Abdominal pain—Sorafenib—liver cancer	0.00553	0.0112	CcSEcCtD
Scopolamine—Body temperature increased—Sorafenib—liver cancer	0.00553	0.0112	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—liver cancer	0.00542	0.011	CcSEcCtD
Scopolamine—Asthenia—Sorafenib—liver cancer	0.00502	0.0102	CcSEcCtD
Scopolamine—Pruritus—Sorafenib—liver cancer	0.00495	0.01	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—liver cancer	0.00482	0.00979	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—liver cancer	0.00464	0.00942	CcSEcCtD
Scopolamine—Dizziness—Sorafenib—liver cancer	0.00463	0.00939	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—liver cancer	0.00455	0.00923	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—liver cancer	0.00446	0.00906	CcSEcCtD
Scopolamine—Vomiting—Sorafenib—liver cancer	0.00445	0.00903	CcSEcCtD
Scopolamine—Rash—Sorafenib—liver cancer	0.00441	0.00896	CcSEcCtD
Scopolamine—Dermatitis—Sorafenib—liver cancer	0.00441	0.00895	CcSEcCtD
Scopolamine—Headache—Sorafenib—liver cancer	0.00438	0.0089	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—liver cancer	0.00429	0.00872	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—liver cancer	0.00425	0.00863	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—liver cancer	0.00421	0.00854	CcSEcCtD
Scopolamine—Nausea—Sorafenib—liver cancer	0.00416	0.00844	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—liver cancer	0.00405	0.00823	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—liver cancer	0.00394	0.008	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—liver cancer	0.00393	0.00799	CcSEcCtD
Scopolamine—Sweating—Epirubicin—liver cancer	0.00389	0.00789	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—liver cancer	0.00375	0.00762	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—liver cancer	0.0037	0.00752	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—liver cancer	0.00365	0.0074	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—liver cancer	0.00361	0.00733	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—liver cancer	0.0036	0.0073	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—liver cancer	0.00359	0.0073	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—liver cancer	0.00357	0.00724	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—liver cancer	0.00351	0.00712	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—liver cancer	0.00343	0.00696	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—liver cancer	0.0034	0.0069	CcSEcCtD
Scopolamine—Flushing—Epirubicin—liver cancer	0.00338	0.00686	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—liver cancer	0.00334	0.00679	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—liver cancer	0.00333	0.00675	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—liver cancer	0.0033	0.0067	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—liver cancer	0.00325	0.0066	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—liver cancer	0.00324	0.00659	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—liver cancer	0.00319	0.00647	CcSEcCtD
Scopolamine—Erythema—Epirubicin—liver cancer	0.00317	0.00643	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—liver cancer	0.00315	0.00639	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—liver cancer	0.00313	0.00634	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—liver cancer	0.00301	0.00611	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—liver cancer	0.00299	0.00606	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—liver cancer	0.00295	0.00599	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—liver cancer	0.00293	0.00595	CcSEcCtD
Scopolamine—Agitation—Epirubicin—liver cancer	0.00291	0.00591	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—liver cancer	0.00285	0.00578	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—liver cancer	0.00276	0.00561	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—liver cancer	0.00269	0.00547	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00268	0.00544	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—liver cancer	0.00264	0.00536	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—liver cancer	0.00263	0.00535	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—liver cancer	0.00261	0.00529	CcSEcCtD
Scopolamine—Oedema—Epirubicin—liver cancer	0.00259	0.00525	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—liver cancer	0.00254	0.00515	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—liver cancer	0.00252	0.00512	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—liver cancer	0.00251	0.0051	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—liver cancer	0.0025	0.00507	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00248	0.00503	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—liver cancer	0.00244	0.00496	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—liver cancer	0.00242	0.00491	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—liver cancer	0.00241	0.0049	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—liver cancer	0.00239	0.00486	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—liver cancer	0.00235	0.00476	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—liver cancer	0.00233	0.00474	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—liver cancer	0.00232	0.00472	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—liver cancer	0.00231	0.0047	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—liver cancer	0.0023	0.00467	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—liver cancer	0.00224	0.00454	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—liver cancer	0.00223	0.00453	CcSEcCtD
Scopolamine—Pain—Epirubicin—liver cancer	0.00221	0.00449	CcSEcCtD
Scopolamine—Constipation—Epirubicin—liver cancer	0.00221	0.00449	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—liver cancer	0.00213	0.00433	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—liver cancer	0.00213	0.00432	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—liver cancer	0.00206	0.00419	CcSEcCtD
Scopolamine—Pain—Doxorubicin—liver cancer	0.00205	0.00415	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—liver cancer	0.00205	0.00415	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—liver cancer	0.00204	0.00415	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—liver cancer	0.00204	0.00415	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—liver cancer	0.00197	0.004	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—liver cancer	0.00189	0.00384	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—liver cancer	0.00189	0.00384	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—liver cancer	0.00186	0.00377	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—liver cancer	0.00183	0.00371	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—liver cancer	0.00172	0.00348	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—liver cancer	0.00171	0.00347	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—liver cancer	0.00169	0.00344	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—liver cancer	0.00164	0.00334	CcSEcCtD
Scopolamine—Rash—Epirubicin—liver cancer	0.00163	0.00331	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—liver cancer	0.00163	0.00331	CcSEcCtD
Scopolamine—Headache—Epirubicin—liver cancer	0.00162	0.00329	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—liver cancer	0.00158	0.00321	CcSEcCtD
Scopolamine—Nausea—Epirubicin—liver cancer	0.00154	0.00312	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—liver cancer	0.00152	0.00309	CcSEcCtD
Scopolamine—Rash—Doxorubicin—liver cancer	0.00151	0.00306	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—liver cancer	0.00151	0.00306	CcSEcCtD
Scopolamine—Headache—Doxorubicin—liver cancer	0.0015	0.00304	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—liver cancer	0.00142	0.00289	CcSEcCtD
Scopolamine—CHRM5—Signaling Pathways—MAPK14—liver cancer	0.000196	0.000386	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP1A1—liver cancer	0.000195	0.000384	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCE—liver cancer	0.000193	0.00038	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ESR1—liver cancer	0.000192	0.000379	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCE—liver cancer	0.000192	0.000378	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	0.00019	0.000375	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCE—liver cancer	0.00019	0.000375	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—F2—liver cancer	0.00019	0.000374	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	0.00019	0.000374	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APC—liver cancer	0.00019	0.000374	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CG—liver cancer	0.00019	0.000374	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PSMD10—liver cancer	0.000188	0.000371	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PSMA4—liver cancer	0.000188	0.000371	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	0.000188	0.000371	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GOT2—liver cancer	0.000183	0.000361	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	0.000183	0.00036	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF2—liver cancer	0.000183	0.00036	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	0.000182	0.000359	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF2—liver cancer	0.000182	0.000359	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CG—liver cancer	0.000182	0.000358	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APC—liver cancer	0.000182	0.000358	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—liver cancer	0.000182	0.000358	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	0.00018	0.000356	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF2—liver cancer	0.00018	0.000355	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	0.000179	0.000353	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—BRAF—liver cancer	0.000178	0.000352	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARA—liver cancer	0.000178	0.000351	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2E1—liver cancer	0.000172	0.000339	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—BRAF—liver cancer	0.000171	0.000337	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CSF2—liver cancer	0.00017	0.000336	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—RAF1—liver cancer	0.00017	0.000335	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CSF2—liver cancer	0.00017	0.000335	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—RAF1—liver cancer	0.00017	0.000334	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CSF2—liver cancer	0.000168	0.000332	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—H2AFX—liver cancer	0.000168	0.000331	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL2—liver cancer	0.000168	0.000331	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—RAF1—liver cancer	0.000168	0.000331	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—H2AFX—liver cancer	0.000167	0.00033	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL2—liver cancer	0.000167	0.00033	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CD—liver cancer	0.000167	0.000329	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	0.000166	0.000327	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—H2AFX—liver cancer	0.000166	0.000327	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL2—liver cancer	0.000166	0.000327	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	0.000165	0.000326	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CA—liver cancer	0.000165	0.000326	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—liver cancer	0.000165	0.000325	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	0.000164	0.000323	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—KRAS—liver cancer	0.000163	0.000322	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000162	0.00032	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYCS—liver cancer	0.000161	0.000317	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CD—liver cancer	0.00016	0.000315	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CA—liver cancer	0.000158	0.000312	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—liver cancer	0.000158	0.000311	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GGT1—liver cancer	0.000158	0.000311	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GOT1—liver cancer	0.000158	0.000311	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—KRAS—liver cancer	0.000156	0.000308	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CG—liver cancer	0.000153	0.000301	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL2—liver cancer	0.000152	0.0003	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL2—liver cancer	0.000152	0.0003	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TERT—liver cancer	0.000152	0.000299	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TERT—liver cancer	0.000151	0.000298	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL2—liver cancer	0.000151	0.000297	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CA—liver cancer	0.00015	0.000296	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TERT—liver cancer	0.00015	0.000296	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RAF1—liver cancer	0.000149	0.000294	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—liver cancer	0.000147	0.00029	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MTOR—liver cancer	0.000145	0.000287	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CB—liver cancer	0.000145	0.000287	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	0.000144	0.000283	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RAF1—liver cancer	0.000143	0.000281	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTP1—liver cancer	0.000142	0.00028	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—liver cancer	0.00014	0.000276	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CB—liver cancer	0.000139	0.000274	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MTOR—liver cancer	0.000139	0.000274	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KDR—liver cancer	0.000139	0.000274	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRAS—liver cancer	0.000139	0.000274	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KDR—liver cancer	0.000139	0.000273	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK14—liver cancer	0.000138	0.000272	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK14—liver cancer	0.000138	0.000271	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KDR—liver cancer	0.000137	0.00027	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDKN1B—liver cancer	0.000137	0.000269	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK14—liver cancer	0.000136	0.000268	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ESR1—liver cancer	0.000135	0.000267	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—liver cancer	0.000135	0.000266	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ESR1—liver cancer	0.000135	0.000266	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CD—liver cancer	0.000134	0.000264	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—liver cancer	0.000134	0.000264	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—F2—liver cancer	0.000134	0.000264	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ESR1—liver cancer	0.000134	0.000263	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL2—liver cancer	0.000134	0.000263	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—F2—liver cancer	0.000133	0.000263	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRAS—liver cancer	0.000133	0.000262	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—liver cancer	0.000133	0.000262	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—liver cancer	0.000132	0.000261	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—F2—liver cancer	0.000132	0.00026	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDKN1B—liver cancer	0.000131	0.000258	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—liver cancer	0.00013	0.000257	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—liver cancer	0.00013	0.000257	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—JUN—liver cancer	0.00013	0.000256	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—liver cancer	0.000129	0.000255	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CTNNB1—liver cancer	0.000129	0.000254	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—liver cancer	0.000128	0.000252	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APC—liver cancer	0.000128	0.000252	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CG—liver cancer	0.000128	0.000252	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL2—liver cancer	0.000128	0.000252	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APC—liver cancer	0.000128	0.000251	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CG—liver cancer	0.000128	0.000251	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—liver cancer	0.000127	0.000251	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—liver cancer	0.000126	0.000249	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APC—liver cancer	0.000126	0.000249	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	0.000126	0.000249	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDKN1A—liver cancer	0.000126	0.000248	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—liver cancer	0.000125	0.000246	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—JUN—liver cancer	0.000124	0.000245	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP1A1—liver cancer	0.000124	0.000244	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CTNNB1—liver cancer	0.000123	0.000243	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—liver cancer	0.000123	0.000242	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—liver cancer	0.000123	0.000242	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—liver cancer	0.000121	0.000239	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDKN1A—liver cancer	0.000121	0.000238	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BRAF—liver cancer	0.00012	0.000237	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BRAF—liver cancer	0.00012	0.000236	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BRAF—liver cancer	0.000119	0.000234	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—liver cancer	0.000118	0.000232	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—liver cancer	0.000117	0.000231	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CB—liver cancer	0.000117	0.00023	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—liver cancer	0.000115	0.000227	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—liver cancer	0.000114	0.000224	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARA—liver cancer	0.000113	0.000223	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CD—liver cancer	0.000113	0.000222	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—liver cancer	0.000112	0.000222	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CD—liver cancer	0.000112	0.000221	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	0.000111	0.00022	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—liver cancer	0.000111	0.000219	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	0.000111	0.000219	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	0.000111	0.000219	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—liver cancer	0.000111	0.000219	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—KRAS—liver cancer	0.00011	0.000217	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	0.00011	0.000217	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	0.00011	0.000216	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—KRAS—liver cancer	0.00011	0.000216	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—KRAS—liver cancer	0.000109	0.000214	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—liver cancer	0.000109	0.000214	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—liver cancer	0.000108	0.000212	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—liver cancer	0.000104	0.000206	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—liver cancer	0.000104	0.000205	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	0.000101	0.000199	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	0.000101	0.000199	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RAF1—liver cancer	0.0001	0.000198	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RAF1—liver cancer	0.0001	0.000197	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—liver cancer	0.0001	0.000197	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	9.99e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—liver cancer	9.98e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RAF1—liver cancer	9.92e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CB—liver cancer	9.81e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MTOR—liver cancer	9.81e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MTOR—liver cancer	9.78e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CB—liver cancer	9.78e-05	0.000193	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CG—liver cancer	9.68e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	9.68e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MTOR—liver cancer	9.68e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KRAS—liver cancer	9.65e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRAS—liver cancer	9.36e-05	0.000185	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—liver cancer	9.34e-05	0.000184	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRAS—liver cancer	9.33e-05	0.000184	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRAS—liver cancer	9.24e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KRAS—liver cancer	9.24e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDKN1B—liver cancer	9.2e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDKN1B—liver cancer	9.17e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—liver cancer	9.1e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	9.09e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—liver cancer	9.08e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—liver cancer	9.02e-05	0.000178	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL2—liver cancer	9.01e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—liver cancer	8.99e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	8.99e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL2—liver cancer	8.98e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—liver cancer	8.96e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—liver cancer	8.93e-05	0.000176	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—liver cancer	8.9e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL2—liver cancer	8.89e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CA—liver cancer	8.87e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—liver cancer	8.85e-05	0.000174	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—liver cancer	8.78e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JUN—liver cancer	8.76e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—liver cancer	8.75e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JUN—liver cancer	8.73e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CTNNB1—liver cancer	8.7e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—liver cancer	8.67e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	8.67e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JUN—liver cancer	8.65e-05	0.00017	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	8.58e-05	0.000169	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—liver cancer	8.58e-05	0.000169	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—liver cancer	8.52e-05	0.000168	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CD—liver cancer	8.51e-05	0.000168	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—liver cancer	8.5e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	8.49e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CA—liver cancer	8.49e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	8.47e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—liver cancer	8.41e-05	0.000166	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—liver cancer	8.4e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	8.38e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—liver cancer	8.29e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—liver cancer	8.27e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—liver cancer	8.26e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—liver cancer	8.24e-05	0.000162	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—liver cancer	8.21e-05	0.000162	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRAS—liver cancer	8.2e-05	0.000162	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—liver cancer	8.18e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—liver cancer	8.16e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRAS—liver cancer	7.86e-05	0.000155	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—liver cancer	7.85e-05	0.000155	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—liver cancer	7.65e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—liver cancer	7.63e-05	0.00015	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—liver cancer	7.58e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—liver cancer	7.56e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—liver cancer	7.56e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—liver cancer	7.52e-05	0.000148	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—liver cancer	7.48e-05	0.000147	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CB—liver cancer	7.42e-05	0.000146	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—liver cancer	7.24e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CA—liver cancer	7.13e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—liver cancer	7.04e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—liver cancer	7.03e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—liver cancer	7.02e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—liver cancer	7e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—liver cancer	6.95e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—liver cancer	6.94e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—liver cancer	6.94e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KRAS—liver cancer	6.51e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KRAS—liver cancer	6.49e-05	0.000128	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KRAS—liver cancer	6.42e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	5.98e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	5.96e-05	0.000117	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	5.9e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—liver cancer	5.82e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—liver cancer	5.78e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—liver cancer	5.77e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—liver cancer	5.71e-05	0.000113	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRAS—liver cancer	5.53e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRAS—liver cancer	5.51e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRAS—liver cancer	5.46e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—liver cancer	5.29e-05	0.000104	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—liver cancer	5.28e-05	0.000104	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—liver cancer	5.23e-05	0.000103	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—liver cancer	4.88e-05	9.62e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—liver cancer	4.87e-05	9.59e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—liver cancer	4.82e-05	9.5e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CA—liver cancer	4.52e-05	8.91e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—liver cancer	3.69e-05	7.28e-05	CbGpPWpGaD
